# Acadia Pharmaceuticals Inc: Form 8-K, filed Dec 11, 2024

- Company: [Acadia Pharmaceuticals Inc](/companies/acad.md) (CIK 1070494)
- Form: 8-K
- Filed: 2024-12-11
- Accepted by EDGAR: Dec 11, 2024, 16:22 ET
- Period: 2024-12-11
- Accession: 0001193125-24-275595
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070494/000119312524275595/d841090d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070494/000119312524275595/

## Items reported

- Item 2.01: Completion of an acquisition or disposition

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1070494/000119312524275595/d841090d8k.htm

Filed Dec 11, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-275595. Last ingested by Listed: Nov 10, 2026, 16:33 ET. No prices; not investment advice.